With so many in our community insured under Medicare Part D or a Medicare Advantage plan, CLL Society wrote to the Center of Medicare and Medicaid Services (CMS) asking for greater oversight of Medicare health plans. We want to insure formularies and insurance practices will not delay or deny patients the treatments they need.
The Inflation Reduction Act (IRA) introduces incentives for health plans to reduce access to treatments while also providing patients much needed financial relief. The out of pocket cap is critical for patients in helping them to afford their drugs, but it should not come at the cost of being denied coverage of needed treatments by their insurer. CLL Society has not only written to CMS (read letter here), we have also met with CMS officials to underscore our concerns.
